3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
16
Carcinoma, Non-Small-Cell Lung
16
Breast Neoplasms
15
Triple Negative Breast Neoplasms
12
Lung Neoplasms
12
Neoplasm Metastasis
11
Ovarian Neoplasms
9
Squamous Cell Carcinoma of Head and Neck
8
Fallopian Tube Neoplasms
7
Endometrial Neoplasms
7
Esophageal Neoplasms
5
Oropharyngeal Neoplasms
4
Neoplasms
4
Melanoma
4
Colorectal Neoplasms
4
Adenocarcinoma Of Esophagus
4
Mouth Neoplasms
3
Laryngeal Neoplasms
3
Cholangiocarcinoma
3
Carcinoma, Transitional Cell
3
Carcinoma
3
Stomach Neoplasms
2
Inflammatory Breast Neoplasms
2
Hypopharyngeal Neoplasms
2
Head and Neck Neoplasms
2
Gallbladder Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Brenner Tumor
2
Anatomic Stage II Breast Cancer AJCC v8
2
Anatomic Stage I Breast Cancer AJCC v8
2
Interventions
Gemcitabine
4
130-nm albumin-bound paclitaxel
4
Cetuximab
3
Bevacizumab
3
pembrolizumab
2
Pemetrexed
2
Paclitaxel
2
Oxaliplatin
2
Leucovorin
2
Fluorouracil
2
Cisplatin
2
Carboplatin
2
Albumin-Bound Paclitaxel
2
relacorilant
1
Long Interspersed Nucleotide Elements
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Pancreatic Ductal
×
Taxes
×
90 days
×
Clear all
No trials found.